March 31, 2020 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19. PBOA’s.
PBOA Members Committed To Continuing To Reliably Manufacture Drug and Vaccine Products
March 19, 2020 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and.
Q&A with Pfizer CentreOne GM JoyL Silva
1. What trends or market dynamics do you think are challenging contract services providers most these days? The top five end-to-end CDMOs still only comprise 15 percent of the market.1 Beyond these, there are about 300 to 400 others vying for contract work.2 That’s a crowd and makes the process of finding the right contract.
PBOA Praises Congressional Action On FDA Reauthorization
HELP, E&C release discussion draft of User Fees Reauthorization